John M.H. Gregg, MBA, CLP
InvestorCommercialization Lead at Iter Investments
Find your path to John
15 people in our graph share verified history with John — schools, employers, funds. One of them is your warm intro.
Andrew HallunlockedJohn: together at Iter Investments
×11John: together at Iter Investments
About
Biotech and pharmaceutical executive with extensive experience in clinical development and commercialization of infectious disease, anti-infective, and oncology products. Currently CEO of BalinBac Therapeutics.
Colleagues at Iter Investments
Amanda Barton
Legal Advisor at Iter Investments
Andrew Hall
Venture Partner at Iter Investments
Andrew Hall, PhD
Scientific Lead at Iter Investments
David Wood, Esq. PhD
Intellectual Property Lead at Iter Investments
Dr. Michelle Weiner, DO MPH
Clinical Lead at Iter Investments
Dr. Scott Fisher, MD
Psychiatric Lead at Iter Investments
Dustin Robinson
Managing Director at Iter Investments
Dustin Robinson, Esq. CPA
Founder at Iter Investments
Frequently asked questions
- Who is John M.H. Gregg, MBA, CLP?
- Biotech and pharmaceutical executive with extensive experience in clinical development and commercialization of infectious disease, anti-infective, and oncology products. Currently CEO of BalinBac Therapeutics.
- Where does John M.H. Gregg, MBA, CLP work?
- John M.H. Gregg, MBA, CLP is Commercialization Lead at Iter Investments.